Table 1 Baseline characteristics and anthropometrical measurements of subjects at screening [%, (mean ± SD) or (median (min-max)]

Age (years)

43.5 ± 10.52

45.5 ± 7.06

0.361^b

Gender (M/F)

14/21

15/20

0.808 ^a

Smokers (%)

28.6

34.3

0.607 ^a

Alcohol consumers (%)

40.0

51.4

0.337 ^a

Physically activity level (PAL)

1.5 ± 0.13

1.5 ± 0.15

0.567 ^b

Anthropometrical measurements

BMI (kg/m²)

28.2 ± 3.19

27.9 ± 3.15

0.685 ^b

Waist circumference (cm)

93.5 ± 8.93

94.2 ± 10.19

0.775 ^b

Hip circumference (cm)

103.4 ± 5.44

103.3 ± 8.06

0.924 ^b

Body Fat Composition (%)

31.3 ± 7.35

31.1 ± 8.11

0.914 ^b

Biochemical parameters (mg/dL)

Plasma glucose

89.0 (68.0-133.0)

88.0 (64.0-125.00)

0.609 ^c

Serum alanine amino transferase

20.0 (7.0-59.0)

24.0 (5.0-62.0)

0.948 ^c

Serum aspartate amino transferase

20.0 (11.0-44.0)

20.0 (10.0-40.0)

0.986 ^c

Serum glutamyl transferase

19.0 (6.0-61.0)

20.0 (9.0-109.0)

0.204 ^c

Serum akaline phosphatase

69.0 (37.0-104.0)

71.0 (28.0-153.0)

0.304 ^c

Serum thyroid-stimulating hormone

1.81(0.54-5.68)

1.96(0.20-5.44)

0.332 ^c

Serum creatinine

0.87 ± 0.16

0.90 ± 0.15

0.398 ^b

Serum C-reactive protein

0.32 (0.09-0.89)

0.32 (0.13-2.75)

0.591 ^c

Total cholesterol

239.0(203.0-288.0)

244.0 (204.0-283.0)

0.488 ^c

HDL-cholesterol

51.0 (38.0-87.0)

50.0 (31.0-93.0)

0.190 ^c

LDL-cholesterol

153.1 ± 24.14

159.2 ± 21.9

0.267 ^b

Triglycerides

141.0 (54.0-370.0)

166.0 (59.0-310.0)

0.226 ^c

Non-HDL-cholesterol

184.9 ± 21.26

193.17 ± 26.32

0.152 ^b

Apolipoprotein A1

156.3 ± 20.41

154.8 ± 26.16

0.796 ^b

Apolipoprotein B

126.0 ± 17.17

131.6 ± 21.69

0.233 ^b

Lipoprotein(a)

20.8 (5.96-165.0)

20.0 (9.40-153.0)

0.533 ^c